# Research Peptide FAQ — Ipamorelin, NAD+, Semaglutide, Tesamorelin — Pure Core Peptides

> Frequently asked questions about four Research Peptide Fundamentals compounds — Ipamorelin, NAD+, Semaglutide, and Tesamorelin — answered plainly from the peer-reviewed literature, with citations.

Direct answers to the most common questions about Ipamorelin, NAD+, Semaglutide, and Tesamorelin, drawn straight from the published research.

## What is ipamorelin?

Ipamorelin is a five-amino-acid synthetic peptide that binds the ghrelin receptor on the pituitary gland, triggering a pulse of the body's own growth hormone. It has never been approved as a drug anywhere and is sold only as a research chemical; its single published human trial did not meet its stated goal [3].

## What does ipamorelin do for you?

In animal and lab studies, Ipamorelin triggers growth-hormone release from the pituitary gland, and has been shown to reduce chemotherapy-related weight loss in ferrets [1] and increase the rate of bone growth in rats [5]. In its one controlled human trial, it did not significantly speed the recovery of bowel function after surgery compared with placebo [3]. There is no approved human use and no proven human benefit demonstrated in a trial.

## What is ipamorelin peptide?

Ipamorelin is a synthetic peptide — a short chain of five amino acids — engineered with two mirror-image amino acids that make it resistant to rapid breakdown in the body, extending how long its signal lasts. It targets the ghrelin receptor on the pituitary gland to trigger growth-hormone release, and it is sold exclusively as a research chemical, not an approved medicine.

## What are the risks of ipamorelin?

The clearest documented risk sits at the class level rather than with Ipamorelin specifically: a related ghrelin-receptor compound caused dose-dependent heart-muscle damage in a 28-day rat study [2]. Beyond that, there is no long-term human safety data for Ipamorelin at all — the only controlled human research is one short surgical-recovery trial and one brief pharmacokinetic study [3][4] — so risks from extended use in people are genuinely unknown rather than ruled out.

## What is NAD supplement used for?

NAD+ and its precursor supplements (NMN and NR) are marketed mainly around energy metabolism and aging, on the idea that topping up a molecule cells naturally lose with age might support cellular energy production and repair. Human trials have shown these supplements reliably raise blood NAD+ levels [7][10], and one trial found an improvement in walking distance and quality-of-life scores in middle-aged adults [7], but a comprehensive 2025 review concluded that the evidence for translating this into broader health outcomes remains limited [6].

## What is the downside of taking NAD+?

The main downside identified in the literature is less about direct harm and more about unproven benefit: a 2025 review found human efficacy data for NAD+ precursors still limited, and cautioned against relying too heavily on rodent studies that may not translate to people [6]. Separately, IV or injectable NAD+ products carry their own documented concerns, including discomfort when infused too quickly and at least one regulatory recall of a compounded injectable product over contamination concerns.

## Is it safe to take NAD daily?

Clinical trials of daily oral NAD+ precursors have generally reported no significant safety issues compared with placebo — one nicotinamide riboside trial found no flushing and no meaningful difference in adverse events at doses up to 1,000 mg per day over 8 weeks [10], and an NMN trial found no safety issues at doses up to 900 mg per day over 60 days [7]. This reflects trial-length usage of weeks to a couple of months, not necessarily years of continuous use, which has not been separately studied.

## Does NAD cause weight gain?

There is no evidence in the cited trials that NAD+ or its precursors cause weight gain. An NMN trial in prediabetic women found no change in body composition over 10 weeks [8], and an NMN trial in middle-aged adults found no increase in a measured biological-age marker [7]. Weight gain does not appear as a documented adverse effect in the human trial data referenced on this guide.

## What is semaglutide?

Semaglutide is a synthetic peptide that mimics GLP-1, a natural gut hormone. It is FDA-approved for type 2 diabetes, chronic weight management, reducing cardiovascular risk in adults with existing heart disease and overweight or obesity, and, since 2025, a metabolic liver condition. It is given as a once-weekly injection or, in a separate formulation, a daily oral tablet [16][17].

## What is semaglutide used for?

Its FDA-approved uses are: lowering blood sugar in type 2 diabetes, reducing body weight in chronic weight management, lowering the risk of serious cardiovascular events in people with established heart disease, and treating a form of metabolic liver disease. It has also reduced the risk of major kidney-disease events in people with type 2 diabetes and chronic kidney disease in a large trial [14][15][16].

## How does semaglutide work?

Semaglutide binds GLP-1 receptors throughout the body. In the pancreas, it boosts insulin release only when blood sugar is already high and reduces glucagon, a hormone that raises blood sugar. It also slows stomach emptying, which extends the feeling of fullness after a meal.

## How does semaglutide work for weight loss?

The weight-loss effect happens mostly in the brain: Semaglutide reaches appetite-control centers in the hypothalamus and brainstem, switching on fullness signals and turning down hunger signals — often described as a quieting of constant background thoughts about food. In a major trial, this translated into an average 14.9% body-weight reduction over 68 weeks, compared with 2.4% for placebo [16].

## What is tesamorelin?

Tesamorelin is a synthetic version of growth hormone-releasing hormone (GHRH), the natural signal that tells the pituitary gland to release growth hormone. It is FDA-approved, but only for reducing excess visceral (deep abdominal) fat in HIV-positive adults with treatment-related fat redistribution [19].

## What does tesamorelin do?

Tesamorelin triggers the pituitary gland to release more of the body's own growth hormone, which in turn raises IGF-1 and promotes fat breakdown, with a particular effect on visceral fat. In its approved patient population, a pooled analysis of five trials found it significantly reduced visceral fat, trunk fat, and liver fat while increasing lean body mass [18].

## How does tesamorelin work?

It binds the GHRH receptor on pituitary cells, activating the same internal signal that leads those cells to make and release growth hormone. That growth hormone then drives IGF-1 production in the liver, and together the two hormones promote fat breakdown, especially in the visceral fat around internal organs [21].

## Will tesamorelin help me lose belly fat?

Tesamorelin's proven evidence for reducing visceral (deep abdominal) fat comes specifically from trials in HIV-positive adults with treatment-related lipodystrophy, where it produced a meaningful, statistically significant reduction in visceral fat compared with placebo [18][20]. That effect did not persist after treatment stopped — visceral fat returned once dosing ended [22]. Whether the same effect would occur in people outside that specific population has not been established by the available trials, and this page does not suggest a use or dose for anyone.

---

Think of this as a friendly explainer, not a doctor's office — we translate the research into plain language and leave prescribing to licensed clinicians.